A review of pharmacological costs of tyrosine kinase inhibitors in first-line for advanced non-small cell lung cancer with activating epidermal growth factor receptor mutations

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Real world prospective data on tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor mutation positive non-small cell lung cancer at the Edinburgh Cancer Centre

Lung Cancer ◽

10.1016/s0169-5002(21)00278-6 ◽

2021 ◽

Vol 156 ◽

pp. S32

Author(s):

Amanda Swan ◽

Zhuang Boh ◽

Ailsa Patrizio ◽

Iain Phillips ◽

Tamasin Evans ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Prospective Data ◽

Analysis of Epidermal Growth Factor Receptor Mutations in Serum Among Japanese Patients Treated With First-Line Erlotinib for Advanced Non–Small-Cell Lung Cancer

Clinical Lung Cancer ◽

10.1016/j.cllc.2015.07.001 ◽

2016 ◽

Vol 17 (1) ◽

pp. 24-29.e1 ◽

Cited By ~ 1

Author(s):

Makoto Nishio ◽

Koichi Goto ◽

Kenichi Chikamori ◽

Toyoaki Hida ◽

Nobuyuki Katakami ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Japanese Patients ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Targeted Therapies for Non-Small Cell Lung Cancer: An Update on Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Inhibitors

Clinical Journal of Oncology Nursing ◽

10.1188/15.cjon.734-742 ◽

2015 ◽

Vol 19 (6) ◽

pp. 734-742 ◽

Cited By ~ 3

Author(s):

Kristen Kreamer ◽

Debbie Riordan

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/j.lungcan.2019.09.017 ◽

2019 ◽

Vol 137 ◽

pp. 113-122 ◽

Cited By ~ 15

Author(s):

Ana C.Z. Gelatti ◽

Alexander Drilon ◽

Fernando C. Santini

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Egfr Mutation ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Management of non-small cell lung cancer harboring epidermal growth factor receptor mutations in the era of first-line osimertinib

Journal of Thoracic Disease ◽

10.21037/jtd.2019.06.16 ◽

2019 ◽

Vol 11 (7) ◽

pp. 2664-2668

Author(s):

Taiki Hakozaki ◽

Yusuke Okuma

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Association of radiomic features with epidermal growth factor receptor mutation status in non-small cell lung cancer and survival treated with tyrosine kinase inhibitors

Nuclear Medicine Communications ◽

10.1097/mnm.0000000000001076 ◽

2019 ◽

Vol 40 (11) ◽

pp. 1091-1098

Author(s):

Changbin Wang ◽

Xinzhe Dong ◽

Xiaorong Sun ◽

Ran Zhang ◽

Ligang Xing

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Mutation Status ◽

Antitumoral Activity of Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harbouring Rare Epidermal Growth Factor Receptor Mutations

Molecular Diagnosis & Therapy ◽

10.1007/s40291-015-0158-z ◽

2015 ◽

Vol 19 (5) ◽

pp. 267-272 ◽

Cited By ~ 5

Author(s):

Matthijs Oyaert ◽

Ingel Demedts ◽

Elke Boone ◽

Franceska Dedeurwaerdere ◽

Jo Vandorpe ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Antitumoral Activity ◽

Small Cell Lung ◽

A review of small-molecule epidermal growth factor receptor-specific tyrosine kinase inhibitors in development for non-small cell lung cancer

Seminars in Oncology ◽

10.1053/j.seminoncol.2003.12.019 ◽

2004 ◽

Vol 31 ◽

pp. 83-92 ◽

Cited By ~ 8

Author(s):

Katrina Y Glover ◽

Roman Perez-Soler ◽

Vassiliki A Papadimitradopoulou

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Molecule ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer

Frontiers in Oncology ◽

10.3389/fonc.2017.00113 ◽

2017 ◽

Vol 7 ◽

Cited By ~ 27

Author(s):

Tristan A. Barnes ◽

Grainne M. O’Kane ◽

Mark David Vincent ◽

Natasha B. Leighl

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Third Generation ◽

Small Cell Lung ◽

Clearing of circulating tumour DNA predicts clinical response to first line tyrosine kinase inhibitors in advanced epidermal growth factor receptor mutated non-small cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2019.12.016 ◽

2020 ◽

Vol 141 ◽

pp. 37-43 ◽

Cited By ~ 1

Author(s):

Eva Boysen Fynboe Ebert ◽

Tine McCulloch ◽

Karin Holmskov Hansen ◽

Hanne Linnet ◽

Boe Sorensen ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Epidermal Growth ◽

Circulating Tumour Dna